Celgene, Bristol-Myers monopolised cancer drug, pharmacies say
Celgene, Bristol-Myers Squibb and two generic drugmakers engaged in a years-long conspiracy to hinder generic competition for a rare cancer medication, Walgreens and Kroger Pharmacies have alleged.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10